SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-241778
Filing Date
2021-08-10
Accepted
2021-08-10 16:01:23
Documents
15
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d122609d8k.htm   iXBRL 8-K 24105
2 EX-99.1 d122609dex991.htm EX-99.1 82531
3 EX-99.2 d122609dex992.htm EX-99.2 38853
7 GRAPHIC g122609g16u83.jpg GRAPHIC 2315
  Complete submission text file 0001193125-21-241778.txt   291064

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20210805.xsd EX-101.SCH 2903
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20210805_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20210805_pre.xml EX-101.PRE 10960
8 EXTRACTED XBRL INSTANCE DOCUMENT d122609d8k_htm.xml XML 3231
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 211159797
SIC: 3841 Surgical & Medical Instruments & Apparatus